Promotie onderzoek

KNMP stelt wetenschappelijk onderzoek voorop. Hier kunt u de meest recente onderzoeken vinden.
Er zijn25resultaten gevonden
Farmacokinetiek en -dynamiek

A Dried blood spot sampling method for VANcomycin and Creatinine monitoring: Earning higher patient satisfaction and a Decrease in costs in Outpatient Parenteral Antibiotic Therapy service (ADVANCED OPAT)

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Moska Hassanzai
  • Promoters prof. dr. Birgit Koch
  • Co-Promoters dr. Brenda C.M. de Winter Hein van Onzeoort
  • Jaar 2021

Outpatient Parenteral Antimicrobial Therapy (OPAT) service provides antimicrobial therapy by parenteral infusion without hospitalization. Vancomycin is a widely used antibiotic in OPAT, however a drawback of its application in OPAT is the need for traditional blood sampling at a blood sampling facility for therapeutic drug monitoring. By developing a dried blood spot sampling method (i.e. a finger prick), enabling patients to collect their own sample at home, the costs of OPAT may be further reduced and patient satisfaction may be increased. 

Farmacokinetiek en -dynamiek

Exploratory PK/PD study of beta-lactam antibiotics in pediatric intensive care patients

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Stef Schouwenburg
  • Promoters prof. dr. Birgit Koch
  • Co-Promoters Dr. E.D. (Enno) Wildschut Prof. Dr. M. (Matthijs) de Hoog A. (Alan) Abdulla
  • Jaar 2021-2025

 A prospective observational PK/PD to study the target attainment for β-lactam antibiotics in critically ill pediatric patients and associated risk factors.

Farmacokinetiek en -dynamiek

The impact of continuous renal replacement therapy and hyperinflammation on the pharmacokinetics in intensive care unit patients

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Tim Smeets
  • Promoters prof. dr. Birgit Koch prof. dr. Diederik Gommers
  • Co-Promoters dr. Nicole G.M. Hunfeld dr. Henrik Endeman
  • Jaar 2021-2023
  1. To study the impact of inflammation on midazolam pharmacokinetics in critically ill covid-19 patients.
  2. To study the impact of continuous renal replacement therapy on target attainment and pharmacokinetics of drugs in critically ill patients.
Farmacokinetiek en -dynamiek

Computational modeling of tumor growth and clonal evolution

  • Universiteit Leiden Universitair Medisch Centrum
  • Promovendus Anyue Yin
  • Promoters Prof Dr Henk-Jan Guchelaar
  • Co-Promoters Dr Dirk Jan Moes
  • Jaar 2017-2022

Use population PK/PD modeling approach and consider evolving resistance development to better understand the development of drug resistance in anti-cancer treatments and to optimize and individualize anti-cancer treatment.

Farmacokinetiek en -dynamiek

Treosulfan pharmacokinetics and dynamics in pediatric allogeneic stem cell transplantation

  • Universiteit Leiden Universitair Medisch Centrum
  • Promovendus Eileen van der Stoep
  • Promoters Prof Dr Arjan Lankester Prof Dr Henk-Jan Guchelaar
  • Co-Promoters Dr J Zwaveling
  • Jaar 2015-2022

Treosulfan is increasingly used in pediatric allogeneic HSCT. Pharmacokinetic data in children is sparse. Also the relationship with acute and late toxicity and clinical outcome is not clear yet. Our aim is to establish a popPK model, investiate the relationship between treosulfan exposure and outcome and to acquire knowledge about the acute and late side effects. 

Farmacokinetiek en -dynamiek

Pharmacometric analyses of systemic therapies within oncology

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Bram Agema
  • Promoters prof. dr. Ron Mathijssen prof. dr. Birgit Koch
  • Co-Promoters Stijn Koolen
  • Jaar 2020-2024

Het onderzoeken van PK/PD relaties middels farmacometrische modellen en de implicaties daarvan op de dagelijkse klinische praktijk op de afdeling oncologie.

Farmacokinetiek en -dynamiek

Post mortem distributie van geneesmiddelen

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus Rogier van der Hulst
  • Promoters D.J. Touw
  • Co-Promoters prof. dr. Roelof Oostra dr. M. Verschraagen
  • Jaar 2015-2020

Bestudering van de post-mortale verdeling van geneesmiddelen.

Pagina 3 van 4